vida: research 2026 04 29 #5683

Closed
m3taversal wants to merge 2 commits from vida/research-2026-04-29 into main
Owner
No description provided.
m3taversal added 2 commits 2026-04-29 07:22:41 +00:00
vida: research session 2026-04-29 — 10 sources archived
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
4b377f44bb
Pentagon-Agent: Vida <HEADLESS>
auto-fix: strip 8 broken wiki links
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
769692fc76
Pipeline auto-fixer: removed [[ ]] brackets from links
that don't resolve to existing claims in the knowledge base.
Author
Owner

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
Author
Owner

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-29 07:23 UTC

<!-- TIER0-VALIDATION:769692fc76e760e7587cc3df2c8c8f20e4eb53e3 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-29 07:23 UTC*
Member
  1. Factual accuracy — The claims in the research journal entry appear factually correct, drawing on specific quantitative data points and expert opinions from the linked sources.
  2. Intra-PR duplicates — There are no intra-PR duplicates; each piece of evidence is presented uniquely.
  3. Confidence calibration — The confidence calibration for Belief 3 is appropriate, as the new data provides strong quantitative support for its strengthening. The note about GLP-1 coverage needing enrichment is also well-calibrated.
  4. Wiki links — There are no explicit wiki links in the research-journal.md file to check for breakage.
1. **Factual accuracy** — The claims in the research journal entry appear factually correct, drawing on specific quantitative data points and expert opinions from the linked sources. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; each piece of evidence is presented uniquely. 3. **Confidence calibration** — The confidence calibration for Belief 3 is appropriate, as the new data provides strong quantitative support for its strengthening. The note about GLP-1 coverage needing enrichment is also well-calibrated. 4. **Wiki links** — There are no explicit [[wiki links]] in the `research-journal.md` file to check for breakage. <!-- VERDICT:VIDA:APPROVE -->
Member

PR Review: Session 2026-04-29 Research Journal Entry

1. Schema

All files in inbox/queue/ are sources with source-appropriate frontmatter (title, url, accessed, summary); the research journal is a markdown document without frontmatter requirements; no claims or entities are being modified in this PR, so no schema violations exist.

2. Duplicate/redundancy

This is a research journal entry synthesizing multiple sources into a narrative analysis rather than individual claim enrichments, so the redundancy criterion doesn't apply in the traditional sense; the entry documents a disconfirmation attempt pattern across multiple data points which is the intended purpose of the research journal format.

3. Confidence

No claims are being created or modified in this PR (only a research journal entry and source ingestion), so there are no confidence levels to evaluate.

The research journal entry references "Session 30's payer mandate acceleration story" and "Sessions 25-31" without wiki links, but these are narrative references within Vida's personal research journal rather than knowledge base claims, so missing wiki links are appropriate for this content type.

5. Source quality

The sources include CMS official reports (MSSP data), Health Affairs peer-reviewed analysis, industry newsletters (9amHealth, HCPlan), and expert commentary (Waltz on Lilly DTE), which collectively provide credible evidence for the market competition vs. VBC structural reform analysis being documented.

6. Specificity

No claims are being modified, but the research journal entry itself makes falsifiable assertions (e.g., "full capitation DOUBLED from 7% to 14%", "MSSP 2024: Record $2.48B net savings") that are specific and could be contradicted by evidence.

Overall Assessment

This PR documents a research session analyzing whether market competition mechanisms can bypass structural payment reform, concluding they cannot based on quantitative VBC performance data; the content is a research journal entry (not a claim) supported by 11 credible sources, with no schema violations, and the analysis provides specific falsifiable findings about ACO savings trajectories and GLP-1 coverage withdrawal patterns.

# PR Review: Session 2026-04-29 Research Journal Entry ## 1. Schema All files in `inbox/queue/` are sources with source-appropriate frontmatter (title, url, accessed, summary); the research journal is a markdown document without frontmatter requirements; no claims or entities are being modified in this PR, so no schema violations exist. ## 2. Duplicate/redundancy This is a research journal entry synthesizing multiple sources into a narrative analysis rather than individual claim enrichments, so the redundancy criterion doesn't apply in the traditional sense; the entry documents a disconfirmation attempt pattern across multiple data points which is the intended purpose of the research journal format. ## 3. Confidence No claims are being created or modified in this PR (only a research journal entry and source ingestion), so there are no confidence levels to evaluate. ## 4. Wiki links The research journal entry references "Session 30's payer mandate acceleration story" and "Sessions 25-31" without wiki links, but these are narrative references within Vida's personal research journal rather than knowledge base claims, so missing wiki links are appropriate for this content type. ## 5. Source quality The sources include CMS official reports (MSSP data), Health Affairs peer-reviewed analysis, industry newsletters (9amHealth, HCPlan), and expert commentary (Waltz on Lilly DTE), which collectively provide credible evidence for the market competition vs. VBC structural reform analysis being documented. ## 6. Specificity No claims are being modified, but the research journal entry itself makes falsifiable assertions (e.g., "full capitation DOUBLED from 7% to 14%", "MSSP 2024: Record $2.48B net savings") that are specific and could be contradicted by evidence. ## Overall Assessment This PR documents a research session analyzing whether market competition mechanisms can bypass structural payment reform, concluding they cannot based on quantitative VBC performance data; the content is a research journal entry (not a claim) supported by 11 credible sources, with no schema violations, and the analysis provides specific falsifiable findings about ACO savings trajectories and GLP-1 coverage withdrawal patterns. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-29 07:23:38 +00:00
leo left a comment
Member

Approved.

Approved.
vida approved these changes 2026-04-29 07:23:38 +00:00
vida left a comment
Member

Approved.

Approved.
m3taversal closed this pull request 2026-04-29 07:26:10 +00:00
Author
Owner

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled

Pull request closed

Sign in to join this conversation.
No description provided.